ANTIFUNGAL PROPHYLAXIS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES - A REAPPRAISAL

被引：94
|
作者：
UZUN, O [1 ]
ANAISSIE, EJ [1 ]
机构：
[1] UNIV TEXAS, MD ANDERSON CANC CTR, DEPT MED SPECIALTIES, HOUSTON, TX 77030 USA
来源：
BLOOD | 1995年 / 86卷 / 06期
关键词：
D O I：
10.1182/blood.V86.6.2063.bloodjournal8662063
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2063 / 2072
页数：10
相关论文
共 50 条
  • [1] Advances in antifungal prophylaxis and empiric therapy in patients with hematologic malignancies
    Murali, S.
    Langston, A.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2009, 11 (06) : 480 - 490
  • [2] Antifungal prophylaxis in neutropenic patients with hematologic malignancies:: Is there a real benefit?
    Böhme, A
    Karthaus, M
    Hoelzer, D
    [J]. CHEMOTHERAPY, 1999, 45 (03) : 224 - 232
  • [3] Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies
    Cornely, OA
    Ullmann, AJ
    Karthaus, M
    [J]. BLOOD, 2003, 101 (09) : 3365 - 3372
  • [4] Antifungal Stewardship Interventions in Patients with Hematologic Malignancies
    Vergidis, Paschalis
    Stevens, Ryan W.
    Agrawal, Samir G.
    [J]. CURRENT FUNGAL INFECTION REPORTS, 2023, 17 (02) : 108 - 118
  • [5] Antifungal Stewardship Interventions in Patients with Hematologic Malignancies
    Paschalis Vergidis
    Ryan W. Stevens
    Samir G. Agrawal
    [J]. Current Fungal Infection Reports, 2023, 17 : 108 - 118
  • [6] Antifungal Prophylaxis and Risk for Invasive Mold Infections in Children with Hematologic Malignancies
    Ikwuezunma, Ashley
    Dutta, Ankhi
    Castellanos, Maria Isabel
    Paek, Hana
    Palazzi, Debra
    Rabin, Karen R.
    Scheurer, Michael E.
    Gramatges, Maria Monica
    [J]. BLOOD, 2020, 136
  • [7] Impact of testing posaconazole plasma concentrations on epidemiology of antifungal prophylaxis and therapy in patients with hematologic malignancies
    Hoenigl, M.
    Valentin, V.
    Raggam, R. B.
    Valentin, A.
    Woelfler, A.
    Seeber, K.
    Zollner-Schwetz, I.
    Krause, R.
    [J]. MYCOSES, 2012, 55 : 96 - 96
  • [8] Population pharmacokinetics (PK) of oral posaconazole (POS) for antifungal prophylaxis in neutropenic patients with Hematologic malignancies
    Abu Tarif, Malaz A.
    Krishna, Gopal
    Statkevich, Paul
    [J]. BLOOD, 2007, 110 (11) : 678A - 678A
  • [9] Prophylaxis of Neutropenia with Mecapegfilgrastim in Patients with Hematologic Malignancies
    Huang, Huiqiang
    Li, Zengjun
    Cheng, Gang
    Yan, Gao
    Yao, Zhihua
    Zhang, Guifang
    Wang, Xiaoguang
    Han, Zhengxiang
    Chen, Yong
    Yan, Haijiao
    Zheng, Weie
    Yan, Jun
    Gu, Yulan
    Ren, Zhangxia
    Zhao, Rusen
    Zhang, Ningling
    Ma, Jun
    [J]. BLOOD, 2021, 138
  • [10] Antifungal prophylaxis and treatment in patients with hematological malignancies
    Hwang, Yu Yan
    Liang, Raymond
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2010, 8 (04) : 397 - 404
12345